인간 기관지 평활근 세포에서 Dexamethasone의 PDGF와 TGF-β에 의해 증강된 Vascular Endothelial Growth Factor 생성 억제 효과
Dexamethasone Attenuates PDGF- and TGF-β-enhanced Vascular Endothelial Growth Factor Production in Cultured Human Bronchial Smooth Muscle Cells
0
조회
0
다운로드
0
인용
0
참고문헌
초록
목 적 : 인간 기관지 평활근 세포는 천식에서 기관지 운동의 톤을 조절할 뿐만 아니라 기도의 면역조절과 기도개형에서 중요한 역할을 담당하고 있다. VEGF는 다양한 기능을 가지고 있는 사이토카인으로 천식양 표현형을 유도하며 염증, 부종, 혈관 개형, 점액질 화생(mucus metaplasia), 상피세포하 섬유화, 기도 항원 감작 그리고 항원유도 Th2 염증 반응을 일으킨다. 또한 TGF-β는 기도개형에서 인간 기관지 평활근세포의 성장을 조절하는 중요한 사이토카인으로 알려져 있으나 천식 기도개형에서의 역할은 명확하지 않다. 본 연구에서는 배양된 기관지 평활근 세포에서 dexamethasone이 PDGF와 TGF-β의 자극에 의한 VEGF의 분비에 어떠한 영향을 미치는지 알아보고자 하였다.방 법 : 10% FCS-DMEM 배지에서 배양된 사람 기관지 평활근세포를 48시간 동안 무혈청 배지에서 성장을 정지시킨 후 dexamethasone (10-5, 10-6 M)와 TGF-β(10 ng/mL)로 전처치하였다. 16시간 후 PDGF(20 ng/mL)로 자극하여 24시간 뒤 배양 상층액을 추출 후 VEGF의 ELISA 측정 전까지 영하 80도에 보관하였다.
Abstract
Purpose : Human bronchial smooth muscle cell(HBSMC) plays an important role in the remodeling of the airways in asthma. Vascular endothelial growth factor(VEGF) is a multifunctional cytokine, which induces edema, angiogenesis, vascular remodeling, mucus metaplasia, subepithelial fibrosis, and antigen-induced Th2 inflammation. Transforming growth factor-beta(TGF-β) is a growth modulator of HBSMC and an important cytokine in airway remodeling. We investigated the effect of dexamethasone on the release of VEGF from HBSMC stimulated with platelet-derived growth factor(PDGF) and TGF-β. Methods : HBSMC cultured in 10 percent FCS-DMEM media was growth-arrested in serum-deprived medium for 48 hours. Dexamethasone and TGF-β were added and incubated for 16 hours before stimulation with PDGF. After 24 hours of stimulation, culture medium was harvested and stored at -80℃ until ELISA for VEGF was performed. Results : The release of VEGF was significantly increased after stimulation with PDGF (P<0.01). The production of VEGF pretreated with TGF-β before stimulation with PDGF was higher than those without TGF-β pretreatment(P<0.01). Dexamethasone suppressed the release of VEGF in HBSMC stimulated with PDGF(P<0.01), TGF-β and PDGF(P<0.01). Conclusion : PDGF and TGF-β may be one of the key mediators in inducing airway remodeling and glucocorticoid, and can be used as useful therapies to prevent airway vascular remodeling by modulating the VEGF on airway smooth muscle cells.
참고문헌 (39)
- "Airway remodeling in asthma", 23, pp.361~368 (2002)
- "What determines asthma phenotype? Is it the interaction between allergy and the smooth muscle?", 161, pp.207~210 (2000)
- "Airway smooth muscle cell proliferation is increased in asthma", 164, pp.474~477 (2001)
- "Effect of interleukin-1 beta,tumor necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells", 121, pp.579~587 (1997)
- "PGE2 release by bradykinin in human airway smooth muscle cells:involvement of cyclooxygenase-2 induction", 273, pp.1132~1140 (1997)
- "Regulation of TNF-alpha- induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and steroids", 15, pp.261~269 (2001)
- "Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cell role of cyclooxygenase products", 161, pp.2509~2515 (1998)
- "Human airway smooth muscle cells secrete vascular endothelial growth factor:upregualtion by bradykinin via a protein kinase C and prostanoid-dependent mechanism", 15, pp.2480~2488 (2001)
- "Platelet-derived growth factor is involved in the augmentation of airway responsiveness through remodeling of airways in diesel exhaust particulate-treated mice", 107, pp.135~142 (2001)
- "Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent", 286, pp.539~545 (2004)
- "The biology of vascular endothelial growth factor", 18, pp.4~25 (1997)
- "Expression of vascular endothelial growth factor,basic fibroblast growth factor,and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis", 107, pp.295~301 (2001)
- "Vascular-endothelial growth factor induces remodeling and enhances Th2 mediated sensitization and inflammation in the lung", 10, pp.1095~1103 (2004)
- "Epithelial- mesenchymal communication in the pathogenesis of chronic asthma", 1, pp.93~98 (2004)
- "Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells:involvement of mitogen-activated protein kinases", 197, pp.453~462 (2003)
- "Airway remodeling in asthma", 123, pp.417~422 (2003)
- "Angiogenic factors", 235, pp.442~7 (1987)
- "Vascular endothelial growth factor is secreted angiogenic mitogens", 246, pp.1306~9 (1989)
- "Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer", 119, pp.333~339 (1996)
- "Gene expression of vascular endothelial growth factor and its receptor and angiogenesis in bronchial asthma", 107, pp.1034~1038 (2001)
- "Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients", 33, pp.595~599 (2003)
- "Vascular permeability factor,an endothelial cell mitogen related to PDGF", 246, pp.1309~12 (1989)
- "Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma", 168, pp.3595~3600 (2002)
- "Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients", 57, pp.885~888 (2002)
- "Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects", 110, pp.571~575 (2002)
- "Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease", 135, pp.332~338 (2000)
- "Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma", 35, pp.1437~1442 (2005)
- "Platelet-derived growth factor:its potential roles in wound healing,atherosclerosis,neoplasia and growth and development", 116, pp.98~112 (1985)
- "Platelet-derived growth factor-1", 25, pp.5154~60 (1982)
- "Platelet-derived growth factor in asthma", 50, pp.878~883 (1995)
- "VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFR beta signaling", 118, pp.3759~3768 (2005)
- "TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice", 58, pp.772~777 (2003)
- "Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid.", 156, pp.642~647 (1997)
- "Eosinophil- associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma", 17, pp.326~333 (1997)
- "Transforming growth factor beta 1(TGF beta 1)gene expression by eosinophils in asthmatic airway inflammation", 15, pp.404~409 (1996)
- "Role of transforming growth factor in human disease", 342, pp.1350~1358 (2000)
- "CD4(+)T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation", 105, pp.61~70 (2000)
- "Is TGF-1 the key to suppression of human asthma", 22, pp.115~118 (2001)
- "Fluticasone inhibits but does not reverse allergen-induced structual airway changes", 163, pp.674~679 (2001)
